Skip to main content
. 2025 Jul 21;15:26499. doi: 10.1038/s41598-025-12583-6

Table 1.

Baseline characteristics of AMI population, across different liver indices (FIB-4, APRI and NFS scores).

Overall for FIB-4 and APRIc
(N = 3287)
FIB-4 < 1.3
(N = 455)
1.3 ≤ FIB-4 < 3.25
(N = 1027)
FIB-4 ≥ 3.25
(N = 1805)
p-value APRI ≤ 0.3
(N = 685)
0.3 < APRI < 1.5
(N = 1369)
APRI ≥ 1.5
(N = 1233)
p-value Overall for NFSb, c
(N = 2143)
NFS < -1.455
(N = 161)
-1.455 ≤ NFS ≤ 0.676
(N = 684)
NFS > 0.676
(N = 1298)
p-value
Demographics a
Age, year 64 (13) 58 (12) 65 (14) 66 (13) p < 0.001 66 (13) 65 (14) 63 (13) p < 0.001 67 (12) 58 (11) 65 (12) 69 (11) p < 0.001
Female 797 (24.2) 117 (25.7) 289 (28.1) 391 (21.7) p < 0.001 228 (33.3) 349 (25.5) 220 (17.8) p < 0.001 545 (25.4) 27 (16.8) 157 (23.0) 361 (27.8) p = 0.002
BMI (kg/m2) c 25.4 (4.7) 26.5 (4.9) 25.4 (4.6) 25.1 (4.7) p < 0.001 25.8 (4.8) 25.4 (4.7) 25.1 (4.6) p = 0.011 25.3 (4.71) 24.6 (4.2) 24.5 (3.9) 25.9 (5.1) p < 0.001
Ethnicity p = 0.006 p = 0.117 p = 0.485
Chinese 1799 (54.7) 211 (46.4) 565 (55.0) 1024 (56.7) 367 (53.6) 768 (56.1) 664 (53.9) 1270 (59.3) 99 (61.5) 399 (58.3) 772 (59.5)
Malay 710 (21.6) 119 (26.2) 221 (21.5) 370 (20.5) 175 (25.5) 278 (20.3) 257 (20.8) 491 (22.9) 38 (23.6) 166 (24.3) 287 (22.1)
Indian 547 (16.6) 90 (19.8) 168 (16.5) 288 (16.0) 100 (14.6) 233 (17.0) 214 (17.4) 290 (13.5) 17 (10.6) 87 (12.7) 186 (14.3)
Caucasian 14 (0.4) 0 5 (0.5) 9 (0.5) 4 (0.6) 4 (0.3) 6 (0.5) 7 (0.3) 0 4 (0.6) 3 (0.2)
Current smoker 961 (29.2) 143 (31.4) 253 (24.6) 565 (31.3) p < 0.001 148 (21.6) 390 (28.5) 423 (34.3) p < 0.001 564 (26.3) 62 (38.5) 199 (29.1) 303 (23.3) p < 0.001
Past medical history a
Hypertension 2153 (65.5) 300 (65.9) 729 (71.0) 1124 (62.3) p < 0.001 537 (78.4) 920 (67.2) 696 (56.4) p < 0.001 1501 (70.0) 84 (52.2) 453 (66.2) 964 (74.3) p < 0.001
Diabetes 1673 (50.9) 280 (61.5) 591 (57.5) 802 (44.4) p < 0.001 445 (65.0) 701 (51.2) 527 (42.7) p < 0.001 1182 (55.2) 46 (28.6) 302 (44.2) 834 (64.3) p < 0.001
Hyperlipidaemia 2084 (63.4) 304 (66.8) 694 (67.6) 1086 (60.2) p < 0.001 498 (72.7) 873 (63.8) 713 (57.8) p < 0.001 1448 (67.6) 96 (59.6) 435 (63.6) 917 (70.6) p < 0.001
Stroke 304 (9.2) 45 (9.9) 100 (9.7) 159 (8.8) p = 0.628 82 (12.0) 127 (9.3) 95 (7.7) p = 0.008 233 (10.9) 7 (4.3) 69 (10.1) 157 (12.1) p = 0.009
Previous AMIc 900 (27.4) 124 (27.3) 374 (36.4) 402 (22.3) p < 0.001 258 (37.7) 407 (29.7) 235 (19.1) p < 0.001 651 (30.4) 31 (19.3) 210 (30.7) 410 (31.6) p = 0.006
Chronic kidney disease 787 (23.9) 107 (23.5) 336 (32.7) 344 (19.1) p < 0.001 253 (36.9) 336 (24.5) 198 (16.1) p < 0.001 606 (28.3) 16 (9.9) 169 (24.7) 421 (32.4) p < 0.001

aCategorical variables are presented as n (%) and continuous variables are presented as mean (standard deviation). p < 0.05 is taken as statistical significance (in bold).

bOut of a total of 3287 patients, 3287 (100%), 3287 (100%), and 2143 (65.2%) had the data necessary to calculate the FIB-4, APRI and NFS respectively.

cAbbreviations: AMI, acute myocardial infarction; APRI, aspartate aminotransferase (AST) to Platelet Ratio Index; ARB, angiotensin receptor blockers; BMI, body mass index; FIB-4, Fibrosis-4 index; NFS, Non-alcoholic Fatty Liver Disease Fibrosis Score.